TORRANCE, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)EPIGENETIC CLOCK DEVELOPMENT FOUNDATION, founded in 2020, is a community nonprofit in the Medical Research sector that reported $2.9M in total revenue in fiscal year 2023. Revenue decreased 20% compared to the prior year. Expenses of $3.5M exceeded revenue, resulting in a 20% operating deficit.
THE CLOCK FOUNDATION WAS FORMED FOR THE SPECIFIC AND PRIMARY PURPOSE OF CONDUCTING MEDICAL RESEARCH ON AGING AND AGE-RELATED DISEASES. DEVELOPING THE EPIGENETIC AGING CLOCK INTO A USEFUL TECHNOLOGY WILL REQUIRE MEDICAL RESEARCH ON AGING AND AGE-RELATED DISEASES. CONSEQUENTLY, THE ACTIVITY WILL ADVANCE CLOCK FOUNDATION'S SPECIFIC PURPOSE OF CONDUCTING MEDICAL RESEARCH ON AGING AND AGE-RELATED DISEASES. IF THE MEDICAL RESEARCH OF THE CLOCK FOUNDATION IS SUCCESSFUL AND THE FDA APPROVES THE CLOCK FOUNDATION'S TESTING METHOD, MANY NEW DRUGS OR TREATMENTS THAT ARE ABLE TO REVERSE EPIGENETIC AGING COULD THEN BE FORMALLY APPROVED BY THE FDA FOR THE TREATMENT OF AGING AND FOR USE IN PREVENTATIVE MEDICINE.
INTERNAL RESEARCH PROGRAM:SINCE INCEPTION WE HAVE FOCUSED ON DEVELOPMENT OF EPIGENETIC CLOCKS AS A KEY ENABLING TECHNOLOGY FOR THE FIELD. WE ARE A SMALL TEAM OF DEDICATED RESEARCHERS, AND THIS YEAR...
INTERNAL RESEARCH PROGRAM:SINCE INCEPTION WE HAVE FOCUSED ON DEVELOPMENT OF EPIGENETIC CLOCKS AS A KEY ENABLING TECHNOLOGY FOR THE FIELD. WE ARE A SMALL TEAM OF DEDICATED RESEARCHERS, AND THIS YEAR HIRED ADDITIONAL PART-TIME OPERATIONAL, ADMIN, AND FINANCE STAFF, ALONG WITH A NEW RESEARCH ASSOCIATE. WE CONTINUED TO WORK CLOSELY WITH OUR SCIENTIFIC ADVISORS, ESPECIALLY ON DEVELOPMENT OF NOVEL TESTING APPROACHES. THE HORVATH MAMMALIAN ARRAY, A KEY ENABLING TECHNOLOGY FOR TRANSLATIONAL AGING RESEARCH, WAS PUBLISHED IN NATURE COMMUNICATIONS, WITH ADDITIONAL PAPERS PUBLISHED IN 2023 IN SCIENCE AND NATURE AGING. ADDITIONAL PAPERS HAVE BEEN RELEASED ON DOGS IN PNAS, CATS, HORSES, SHEEP, MARSUPIALS, NAKED MOLE RATS, AND MANY OTHERS. THE PAPERS DESCRIBE THE DISCOVERY OF UNIVERSAL MAMMALIAN AGING CLOCKS & EPIGENETIC PREDICTORS OF MAXIMUM LIFESPAN.
EXTERNAL RESEARCH COLLABORATIONS: INTERVENTIONAL LONGEVITY STUDIES WE CONDUCTED MANY NEW INTERVENTIONAL STUDIES, FOR CLINICAL TRIALS AND ALSO PRECLINICAL STUDIES. THIS INCLUDES STUDIES ON...
EXTERNAL RESEARCH COLLABORATIONS: INTERVENTIONAL LONGEVITY STUDIES WE CONDUCTED MANY NEW INTERVENTIONAL STUDIES, FOR CLINICAL TRIALS AND ALSO PRECLINICAL STUDIES. THIS INCLUDES STUDIES ON PLASMAPHARESIS, YOUNG PLASMA TREATMENT, STEM CELL EXOSOMES, BONE MARROW TRANSPLANTS, UMBILICAL CORD PLASMA, ANTIRETROVIRAL TREATMENTS, AND A SENOLYTIC GENE THERAPY. WE ALSO COMPLETED ANALYSIS FOR A >1,000-PERSON LONGITUDINAL STUDY OF TESTOSTERONE TREATMENT, ANALYZING ITS EFFECTS ON ESTABLISHED CLINICAL & FUNCTIONAL AGING BIOMARKERS. MECHANISMS OF AGING STUDIES THERE WERE MANY NOTABLE MECHANISTIC STUDIES THIS PAST YEAR INCLUDING FROM THE HOCHEDLINGER LAB ON THE ROLE OF CELLULAR HETEROGENEITY IN EPIGENETIC CLOCK RESULTS, THE DALEY LAB ON LIN28'S ROLE IN REPROGRAMMING, THE LEVIN LAB ON LIMB REGENERATION, THE GLADYSHEV LAB ON BONE MARROW TRANSPLANTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $2,885,392 | $3,593,807 | -0.2% |
| Expenses | $3,453,461 | $3,391,084 | +0.0% |
| Net Income | $-568,069 | $202,723 | -3.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ROBERT BROOKE | EXECUTIVE DIRECTOR | 40.00 |
Officer
Director
|
$120,000 | $0 | $120,000 |
| STEFAN HORVATH | DIRECTOR, CHAIRMAN | 40.00 |
Director
|
$120,000 | $0 | $120,000 |
| DEAN PRISSMAN | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $2,885,392 | $3,453,461 | $954,701 | $-568,069 |
| 2022 | $3,593,807 | $3,391,084 | $1,193,723 | $202,723 |
| 2021 | $2,774,349 | $2,373,123 | $708,627 | $401,226 |
| 2020 | $533,454 | $284,532 | $261,972 | $248,922 |
Compare EPIGENETIC CLOCK DEVELOPMENT FOUNDATION with other nonprofits in California and across the country.